Tel Aviv [Israel], April 24 (ANI/ TPS): India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress. (ANI/ TPS)
You may also like
Muslim clerics, netas back operation against Pakistan terror infra
Columbia University protests: Two police officers injured after 'outrageous' crowd surge
Chennai Super Kings Triumph Over Kolkata Knight Riders in Thrilling IPL Match
KKR Captain Ajinkya Rahane Reflects on Narrow Loss to CSK in IPL Clash
Chennai Super Kings Triumph Over Kolkata Knight Riders in IPL 2025